Effect of 3,4-diaminopyridine on the tim
β
Paul Maddison; John Newsom-Davis; Kerry R. Mills
π
Article
π
1998
π
John Wiley and Sons
π
English
β 123 KB
π 2 views
Diaminopyridine (3,4-DAP) is known to be beneficial in the symptomatic treatment of the Lambert-Eaton myasthenic syndrome (LEMS). The effects of 3,4-DAP on the decay of postexercise augmentation were observed in 6 patients with LEMS. After 10 s maximal voluntary contraction, the amplitude of the co